- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 13, 2025 | 17.16M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $295.53M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $295.66M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $1.85M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $1.85M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $19.66M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $19.41M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $65.35M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $66.09M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $560.03M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $555.43M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $80.53M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $79.96M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $445.13M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $455.83M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$99.6M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $22.33M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 18.99M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $877K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $1.9M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.93 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.93 |
| Net Income | Q1 2025 · Mar 31, 2024 | −$17.59M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$7.38M |
| Revenue | Q1 2025 · Mar 31, 2024 | $75.98M |